Catalog No.S4430 Synonyms: HCQ
Molecular Weight(MW): 433.95
Hydroxychloroquine Sulfate is an antimalarial agent used for the treatment of systemic lupus erythematosus, rheumatoid arthritis and other autoimmune, inflammatory and dermatologic conditions. Also acts as an inhibitor of autophagy and toll-like receptor (TLR) 7/9.
Cited by 9 Publications
4 Customer Reviews
C, SA-beta gal staining results of A549-LKB1 cells treated by trametinib (30 nmol/L), radiotherapy (2 Gy), and HCQ (50 μmol/L). Cells were treated by HCQ and/or trametinib 4 hours prior to radiotherapy. Drugs were washed out 24 hours after radiotherapy. Cells were incubated for additional 48 hours before staining. D, Clonogenic survival assay of A549-LKB1 cells treated with trametinib (30 nmol/L) and HCQ (50 μmol/L).
Clin Cancer Res, 2018, doi:10.1158/1078-0432.CCR-18-1489. Hydroxychloroquine Sulfate purchased from Selleck.
Expression levels of LC3-I and LC3-II were analyzed by western blotting at 80 and 120 min following BBR-SDT with or without 3MA- and hydroxychloroquine-pretreatments. Quantification of the LC3-II/LC3-I ratios are shown (n=3; *Po0.05, **Po0.01, ***Po0.001 versus control, # P<0.05, ##P<0.01 versus BBR-SDT groups)
Cell Death Dis, 2017, 8(1):e2558. Hydroxychloroquine Sulfate purchased from Selleck.
The effect of 3-MA, hydroxychloroquine, and ba A1 with or without HSYA-SDT on the expression levels of the autophagy-related proteins p62 and LC3 and quantifications of the LC3-ΙΙ/LC3-Ι ratio and p62 are shown. All data are mean ± standard error (n=5). ∗
Oxid Med Cell Longev, 2017, 8519169. Hydroxychloroquine Sulfate purchased from Selleck.
(A) CNE-2 and HONE-1 cells were treated with lapatinib (0–10 μM) or DMSO control for 48 hours in the presence or absence of 20 μM of HCQ. At the end of treatment, cell viability was assessed by CCK-8 assay. Results are shown as the mean ± standard deviation. *P<0.05; **P<0.01. (B) CNE-2 and HONE-1 cells were treated with lapatinib (0–5 μM) or DMSO control for 48 hours. Phospho-eEF-2 and eEF-2 were examined by western blotting. GAPDH was used as a loading control.
Onco Targets Ther, 2016, 9:6195-6201.. Hydroxychloroquine Sulfate purchased from Selleck.
Purity & Quality Control
Choose Selective Autophagy Inhibitors
|Description||Hydroxychloroquine Sulfate is an antimalarial agent used for the treatment of systemic lupus erythematosus, rheumatoid arthritis and other autoimmune, inflammatory and dermatologic conditions. Also acts as an inhibitor of autophagy and toll-like receptor (TLR) 7/9.|
Hydroxychloroquine Sulfate is a potent inhibitor of autophagy. It prevents lysosomal acidification, thereby interfering with a key step in the autophagic process.HCQ treatment inhibits RCC (renal cell cancer) cell growth, promotes apoptosis, inhibits mitochondrial oxygen consumption, and increases rates of glycolysis.
|In vivo||The treatment of Hydroxychloroquine Sulfate reduces the infarct size in an in vivo rat model of I/R injury and the cardioprotective effect of Hydroxychloroquine is ERK1/2 dependent. In addition, Hydroxychloroquine Sulfate shows an early vascular protective effect. HCQ seems to prevent the occurrence of endothelial dysfunction(ED) in treated animals.|
In vitro kinase assays:with purified proteins, recombinant S6 protein and recombinant active P70S6K are incubated in 1x kinase buffer with various amount of HCQ or RAD001 in the presence (25 μM) or absence of ATP for 30 minutes at 30°C. Total and phosphorylated S6 at ser235/236 and ser240/244 are detected by western analysis using phosphospecific antibodies. Note that recombinant GST-tagged S6 (53 kd) is distinguished from endogenous S6 (32 kd) on the western blot.
|In vitro||Water||67 mg/mL (154.39 mM)|
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).
Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )
* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).
Molecular Weight Calculator
Enter the chemical formula of a compound to calculate its molar mass and elemental composition:
Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2
Instructions to calculate molar mass (molecular weight) of a chemical compound:
To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
Clinical Trial Information
|NCT Number||Recruitment||Conditions||Sponsor/Collaborators||Start Date||Phases|
|NCT03592823||Recruiting||Atrial Fibrillation||First Affiliated Hospital of Harbin Medical University||August 1 2018||Phase 4|
|NCT02874287||Recruiting||Coronary Artery Disease||First Affiliated Hospital Xi''an Jiaotong University||October 8 2017||Phase 4|
|NCT02942381||Completed||IgA Patients|Hydroxychloroquine||Peking University First Hospital||September 13 2016||Phase 2|
|NCT02765594||Recruiting||Primary IgA Nephropathy||Peking Union Medical College Hospital||June 2016||Phase 4|
|NCT02615938||Recruiting||Interstitial Lung Disease|Diffuse Parenchymal Lung Disease|Children´s Interstitial Lung Disease||Matthias Griese|Ludwig-Maximilians - University of Munich||April 2015||Phase 2|
|NCT02351752||Completed||Primary IgA Nephropathy||LLiu|Peking University First Hospital||January 2015||Phase 4|
Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.